Log In
BCIQ
Print this Print this
 

Vasculan, oral ifetroban

  Manage Alerts
Collapse Summary General Information
Company Cumberland Pharmaceuticals Inc.
Description 
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationScleroderma
Indication DetailsTreat systemic sclerosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today